
Sign up to save your podcasts
Or


Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
By The JAMA Network4.9
1212 ratings
Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial

137 Listeners

320 Listeners

699 Listeners

497 Listeners

36 Listeners

103 Listeners

292 Listeners

3,348 Listeners

38 Listeners

13 Listeners

16 Listeners

19 Listeners

7 Listeners

1,145 Listeners

29 Listeners

193 Listeners

93 Listeners

513 Listeners

369 Listeners

425 Listeners

18 Listeners

374 Listeners

61 Listeners